Effects of losartan/diuretic combination treatment on serum uric acid levels in hypertensive patients

American Journal of Cardiology

Volumn 88, Issue 9, 2001, Pages 1084-

  Milionis, Haralampos J ^a   Nikas, Spyros ^a   Elisaf, Moses S ^a  

^a NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANGIOTENSIN ANTAGONIST; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOSARTAN;

BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERURICEMIA; MORTALITY; NOTE; PATIENT COUNSELING; PRIORITY JOURNAL; TOXICITY; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

ANTIHYPERTENSIVE AGENTS; DIURETICS; DRUG THERAPY, COMBINATION; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; SODIUM CHLORIDE SYMPORTER INHIBITORS; URIC ACID;

EID: 0035499388     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01959-2     Document Type: Letter

References (9)

1. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension
2. Uric acid as an independent risk factor in the treatment of hypertension
3. Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: Case histories
4. Asymptomatic hyperuricemia: Risks and consequences in the normative aging study
5. Pilot study of the uricosuric effect of DuP-753: A new angiotensin II receptor antagonist, in healthy subjects
6. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia
7. Effect of micronised fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia
8. Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes
9. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide